Informazioni sul prodotto
BMS 819881 is a pharmacologic agent that has been shown to improve insulin sensitivity in humans. It is an amide protonated molecule that has potential use for the treatment of obesity and metabolic disorders. BMS 819881 binds to the ATP-binding pocket of the insulin receptor and activates its signaling pathway, leading to enhanced insulin sensitivity. This drug also increases proton conductance through the membrane, which may be due to its effects on ion channels or by enhancing lipid metabolism. Pharmacokinetic studies have demonstrated that BMS 819881 is well-tolerated with a safety profile similar to placebo. Clinical studies have shown that this drug can be achieved at doses as low as 0.5 mg per day, which is lower than other pharmacologic agents used for weight loss.
Proprietà chimiche
Richiesta tecnica su: 3D-XXB42005 BMS 819881
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
